264 related articles for article (PubMed ID: 35658686)
1. Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study.
Al Harbi S; Kensara R; Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Vishwakarma R; Alenazi AM; Almutairi A; Alshaya O; Alraddadi S; Al Sulaiman T; Aldakkan L; Mahboob R; Alaamer K; Alissa A; Hafiz A; Aldhayyan N; Althewaibi S; Alenezi F; Alkhotani NY; Alghamdi SA; Alenazi AA; Al Sulaiman K
Clin Appl Thromb Hemost; 2022; 28():10760296221103864. PubMed ID: 35658686
[TBL] [Abstract][Full Text] [Related]
2. The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study.
Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi AF; Al Harbi S; Al Shaya A; Badreldin HA; Kensara R; Alharthi AF; Alghamdi J; Alawad A; Alotaibi R; Kharbosh A; Al Muqati H; Alhuwahmel A; Almusallam M; Albarrak G; Al Sulaihim I; Alanazi B; Al-Dosari BS; Vishwakarma R; Alsaeedi AS; Al Ghamdi G; Alkofide H; Al-Dorzi HM
Front Public Health; 2022; 10():877944. PubMed ID: 36033795
[TBL] [Abstract][Full Text] [Related]
3. The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study.
Aljuhani O; Al Sulaiman K; Korayem GB; Altebainawi AF; Alsohimi S; Alqahtani R; Alfaifi S; Alharbi A; AlKhayrat A; Hattan A; Albassam M; Almohammed OA; Alkeraidees A; Alonazi DA; Alsalman WF; Aldamegh G; Alshahrani R; Vishwakarma R
Sci Rep; 2024 Feb; 14(1):3037. PubMed ID: 38321099
[TBL] [Abstract][Full Text] [Related]
4. The association between statin therapy during intensive care unit stay and the incidence of venous thromboembolism: a propensity score-adjusted analysis.
Al Harbi SA; Khedr M; Al-Dorzi HM; Tlayjeh HM; Rishu AH; Arabi YM
BMC Pharmacol Toxicol; 2013 Nov; 14():57. PubMed ID: 24206781
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study.
Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Badreldin HA; Alsalloum MA; Eljaaly K; Alharbi A; Aljehani R; Vishwakarma R; Alenazi AA; Alalawi M; Alissa A; Al Aamer K; Al Enazi H; Almusallam M; Alshehri A; Bukhari R; Alasmari G; AlQahtani MM; Al Shammari S; Alsulaymi HO; Al Sulaiman K
J Intensive Care Med; 2023 Jun; 38(6):534-543. PubMed ID: 36683420
[No Abstract] [Full Text] [Related]
6. Doxycycline's Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study.
Al Sulaiman K; Aljuhani O; Korayem GB; Alnajjar LI; Altebainawi AF; AlFaifi M; Vishwakarma R; Alenazi AA; Alalawi M; Alissa A; Alsowaida YS; Alsohimi S; Almagthali A; Alay SM; Altaher N; Alamri MG; Alangari D; Alzahrani A; Abdul Razack HI; Alhamoud J; Alshaya A; Gramish J; Al Aamer K; Alsaeedi AS; Alghamdi G
Clin Appl Thromb Hemost; 2023; 29():10760296231177017. PubMed ID: 37322869
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.
Al Sulaiman K; Aljuhani O; Al Dossari M; Alshahrani A; Alharbi A; Algarni R; Al Jeraisy M; Al Harbi S; Al Katheri A; Al Eidan F; Al Bekairy AM; Al Qahtani N; Al Muqrin M; Vishwakarma R; Al Ghamdi G
Crit Care; 2021 Jun; 25(1):223. PubMed ID: 34193235
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.
Al Harthi AF; Aljuhani O; Korayem GB; Altebainawi AF; Alenezi RS; Al Harbi S; Gramish J; Kensara R; Hafidh A; Al Enazi H; Alawad A; Alotaibi R; Alshehri A; Alhuthaili O; Vishwakarma R; Bin Saleh K; Alsulaiman T; Alqahtani RA; Hussain S; Almazrou S; Al Sulaiman K
J Intensive Care Med; 2022 Sep; 37(9):1238-1249. PubMed ID: 35450493
[TBL] [Abstract][Full Text] [Related]
9. Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study.
Aljuhani O; Al Sulaiman K; Hafiz A; Eljaaly K; Alharbi A; Algarni R; Al Homaid S; Kahtani K; Alsulaiman T; Vishwakarma R; Al Ghamdi G; Alalawi M; Korayem GB
Saudi Pharm J; 2022 Apr; 30(4):398-406. PubMed ID: 35136364
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
Al Sulaiman K; Korayem GB; Altebainawi AF; Al Harbi S; Alissa A; Alharthi A; Kensara R; Alfahed A; Vishwakarma R; Al Haji H; Almohaimid N; Al Zumai O; Alrubayan F; Asiri A; Alkahtani N; Alolayan A; Alsohimi S; Melibari N; Almagthali A; Aljahdali S; Alenazi AA; Alsaeedi AS; Al Ghamdi G; Al Faris O; Alqahtani J; Al Qahtani J; Alshammari KA; Alshammari KI; Aljuhani O
Crit Care; 2022 Oct; 26(1):304. PubMed ID: 36192801
[TBL] [Abstract][Full Text] [Related]
11. Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
Bikdeli B; Talasaz AH; Rashidi F; Sharif-Kashani B; Farrokhpour M; Bakhshandeh H; Sezavar H; Dabbagh A; Beigmohammadi MT; Payandemehr P; Yadollahzadeh M; Riahi T; Khalili H; Jamalkhani S; Rezaeifar P; Abedini A; Lookzadeh S; Shahmirzaei S; Tahamtan O; Matin S; Amin A; Parhizgar SE; Jimenez D; Gupta A; Madhavan MV; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Mohebbi B; Piazza G; Kirtane AJ; Lip GYH; Krumholz HM; Goldhaber SZ; Sadeghipour P
Thromb Res; 2020 Dec; 196():382-394. PubMed ID: 32992075
[TBL] [Abstract][Full Text] [Related]
12. Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study.
Al Sulaiman K; Aljuhani O; Korayem GB; Hafiz A; Alalawi M; Badreldin HA; Altebainawi AF; Vishwakarma R; Alissa A; Alghamdi A; Alenazi AA; Al Enazi H; Alanazi S; Alhammad A; Alghamdi J; AlFaifi M; Al Sehli FA; Aldossari MA; Alhubaishi AA; Al-Ali AY; Al-Dorzi HM
Thromb J; 2022 Dec; 20(1):74. PubMed ID: 36482388
[TBL] [Abstract][Full Text] [Related]
13. When antivirals backfire: An evaluation of favipiravir's clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study.
Al Sulaiman K; Aljuhani O; Korayem GB; Altebainawi AF; AlFaifi M; Nahari M; Almagthali A; Thabit AK; Alhajaji R; Alharbi R; Kahtani K; Alenazi AA; Alharbi A; Alghwainm MM; Alotaibi SM; Alghamdi YS; Alotaibi S; Alonazi SH; Almutairi JM; Vishwakarma R
J Infect Public Health; 2023 Sep; 16(9):1492-1499. PubMed ID: 37355406
[TBL] [Abstract][Full Text] [Related]
14. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19.
Al-Samkari H; Gupta S; Leaf RK; Wang W; Rosovsky RP; Brenner SK; Hayek SS; Berlin H; Kapoor R; Shaefi S; Melamed ML; Sutherland A; Radbel J; Green A; Garibaldi BT; Srivastava A; Leonberg-Yoo A; Shehata AM; Flythe JE; Rashidi A; Goyal N; Chan L; Mathews KS; Hedayati SS; Dy R; Toth-Manikowski SM; Zhang J; Mallappallil M; Redfern RE; Bansal AD; Short SAP; Vangel MG; Admon AJ; Semler MW; Bauer KA; Hernán MA; Leaf DE;
Ann Intern Med; 2021 May; 174(5):622-632. PubMed ID: 33493012
[TBL] [Abstract][Full Text] [Related]
15. Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units.
Lavinio A; Ercole A; Battaglini D; Magnoni S; Badenes R; Taccone FS; Helbok R; Thomas W; Pelosi P; Robba C;
Crit Care; 2021 Apr; 25(1):155. PubMed ID: 33888132
[TBL] [Abstract][Full Text] [Related]
16. The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study.
Korayem GB; Aljuhani O; Altebainawi AF; Shaya AIA; Alnajjar LI; Alissa A; Aldhaeefi M; Kensara R; Al Muqati H; Alhuwahmel A; Alhuthaili O; Vishwakarma R; Aldardeer N; Eljaaly K; Alharbi A; Harbi SA; Katheri AA; Bekairy AMA; Aljedai A; Al Sulaiman K
Int J Infect Dis; 2022 Sep; 122():252-259. PubMed ID: 35605948
[TBL] [Abstract][Full Text] [Related]
17. Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching.
Lohia P; Kapur S; Benjaram S; Cantor Z; Mahabadi N; Mir T; Badr MS
Cardiovasc Diabetol; 2021 Jul; 20(1):140. PubMed ID: 34246277
[TBL] [Abstract][Full Text] [Related]
18. Association between statin therapy and outcomes in critically ill patients: a nested cohort study.
Al Harbi SA; Tamim HM; Arabi YM
BMC Clin Pharmacol; 2011 Aug; 11():12. PubMed ID: 21819615
[TBL] [Abstract][Full Text] [Related]
19. The risk of venous thromboembolism and blood hyperlactatemia is associated with increased mortality among critically ill patients with Covid-19.
Alshammary AF; AlQarni HM; Farzan R; Ali Khan I; Vennu V
Clin Respir J; 2023 Jun; 17(6):580-588. PubMed ID: 37144596
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism.
Bellmunt-Montoya S; Riera C; Gil D; Rodríguez M; García-Reyes M; Martínez-Carnovale L; Marrero C; Gil M; Ruiz-Rodríguez JC; Ferrer R; de Nadal M; Monreal M; Llagostera S
Eur J Vasc Endovasc Surg; 2021 Apr; 61(4):628-634. PubMed ID: 33583710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
